Board Member
Amylyx Pharmaceuticals, Inc. (AMLX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Recorded current and former roles; source labels appear when available.
2021-01-01–present
Start not stated–2021-01-11
Recorded roles and earnings-call appearances connecting this person to public companies.
CFO, Board Member
2021-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Financial Officer | $540,600 | $1,375,327 |
| 2024 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Financial Officer | $540,600 | $2,540,353 |
| 2023 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Financial Officer | $510,000 | $3,510,377 |
| 2022 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Financial Officer | $439,500 | $3,658,945 |
| 2021 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Financial Officer | $375,000 | $3,255,900 |
Earnings-call appearances and filed executive appointments or departures, newest first.
